working with the elderly. He took on administrative roles
at several hospitals and nursing homes, but what he really
wanted to do was teach. After completing coursework
at the University of Michigan for his doctorate in health
services organization, he accepted an assistant professor
position at Ithaca College in 1994, with plans to eventually
finish his dissertation.
Then, in the summer of 1996, Riter felt a hard lump the
size of an eraser on a pencil behind his left nipple. Weeks
later, he noticed the nipple was bleeding. He saw his
primary care doctor, who referred him to a surgeon. After
a fine-needle biopsy and an excisional biopsy of his lump,
Riter had a mastectomy. As part of the procedure, his axillary lymph nodes were biopsied, which revealed that he
had stage II breast cancer.
After his mastectomy, Riter was getting ready to start
another semester of teaching. Worried that his students might
be alarmed if he started losing his hair from chemotherapy, he
decided to share details of his diagnosis and treatment.
“I found that a lot of the students had known someone with
cancer, but they never felt comfortable asking that person
questions about their cancer, so they asked me, and I liked
that,” he says. “I like taking away the mystery of cancer.”
While teaching full time, Riter completed chemotherapy
in six months and started taking tamoxifen, a treatment that
can reduce the risk of breast cancer recurrence. The recom-
mended length of treatment at the time was five years, but
after three months and with his oncologist’s approval, he
stopped taking tamoxifen because of its side effects.
In the summer of 1997, Riter submitted a column to
Newsweek magazine that described in a humorous and
At a Glance: Breast Cancer in Men
Breast cancer in men is rare, making up just a little under 1 percent of new breast
cancer cases each year. In 2018, about 266,120 new cases of invasive breast cancer will
be diagnosed among women, while 2,550 cases will be diagnosed in men, according to
the American Cancer Society. A man’s lifetime risk of developing breast cancer is about
1 in 833, compared with 1 in 8 for women, although men tend to have higher death rates
from the disease than women do.
Your doctor may tell you that your chemotherapy treatment will most likely lead to
hair loss. In addition to scalp hair loss, you may also lose your eyebrows. While scalp
hair loss can be disguised, the loss of eyebrows can be di;cult to conceal and is often
perceived by patients as an unwelcome, visible sign of their illness.
RMV Trademarks, LLC, has developed a unique, patented product called EES-Essential
Eyebrow Solution®. EES is a clinically-tested, topical formulation that is used
cosmetically to address eyebrow thinning or loss, while conditioning and revitalizing
the brows. EES is safe and non-irritating, paraben-free, hypoallergenic, and pH
A recent EES clinical trial published in PRIME International Journal of Aesthetic &
Anti-Ageing Medicine demonstrated that 91% of the 117 enrolled cancer patients
retained 50-100% of their eyebrow hair while undergoing chemotherapy
treatment, despite experiencing full body hair loss elsewhere. The article
“Preserving Eyebrow Hair during Chemotherapy Treatment” was written in
collaboration with Josephine Ford Cancer Institute/Henry Ford Health System,
located in Detroit, Michigan.
Introducing EES – Essential Eyebrow Solution®
. . . A Solution for a Problem
TO LEARN MORE ABOUT EES, please visit www.essentialeyebrowsolution.com, or call 1-888-208-5081.
Chemotherapy regimen consisted of: Perjeta, Taxotere,
Carboplatin & Herceptin (every 3 weeks x 6 cycles),
followed by Herceptin every 3 weeks for 1 year.
The ability to maintain my natural eyebrows
during my treatment made a signi;cant
psychological di;erence when dealing with
my other losses. With a wig, eyeliner and the
preservation of my own eyebrows, others
frequently commented on their amazement
that I had not lost my hair... when indeed I
had. The loss of eyelashes and the hair on
one’s head are far easier to conceal than the
loss of one’s eyebrows. Thank you for the
opportunity to use this product during my
Nurse Anesthetist and Former Cancer Patient
Patient retained her eyebrows despite
full body hair loss elsewhere